Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 52Fallopian Tube Neoplasms 48Endometrial Neoplasms 17Uterine Cervical Neoplasms 16Carcinoma, Ovarian Epithelial 15Brenner Tumor 15Carcinoma, Non-Small-Cell Lung 7Breast Neoplasms 7Esophageal Neoplasms 6Pancreatic Neoplasms 5Neoplasm Metastasis 5Endometrial Adenocarcinoma 5Stomach Neoplasms 4Melanoma 4Lung Neoplasms 4Triple Negative Breast Neoplasms 3Testicular Neoplasms 3Prostatic Neoplasms 3Peritoneal Neoplasms 3Neoplasms 3Carcinoma, Renal Cell 3Uterine Neoplasms 2Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Sarcoma 2Salivary Gland Neoplasms 2Recurrence 2Platinum-Refractory Fallopian Tube Carcinoma 2Ovarian Germ Cell Cancer 2

Interventions

nirogacestat 1etoposide phosphate 1Taxes 1Platinum 1Paclitaxel 1Immunoglobulin G 1Disulfides 1Cisplatin 1Carboplatin 1Bleomycin 1Bevacizumab 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Granulosa cell tumor of the ovary × Taxes × Gynecologic × Clear all
NCT01042522 2022-01-25

Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors

GOG Foundation

Phase 2 Unknown
63 enrolled 16 charts
Gynecologic

Granulosa cell tumor of the ovary, Ovarian gynandroblastoma, Sertoli-Leydig Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡